Large Cap Biotech Analyst Fye holds a conference call with CEO Greenstreet on April 9 at 11 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALNY:
- Alnylam Pharmaceuticals presents results from KARDIA-2 Phase 2 study
- Roche, Alnylam report KARDIA-2 study met primary endpoint
- Alnylam reports KARDIA-2 zilebesiran study met primary endpoint of lower SBP
- Alnylam Pharmaceuticals Finalizes Exit Deal with EVP Franchini
- Alnylam Pharmaceuticals’ New Regulation Risk – A Cause for Worry?